Zhengbin Yao
President and CEO at ArriVent BioPharma Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2024
5 years of board service in total across 2 boards, counting each seat separately. Longest: ArriVent BioPharma Inc., 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Alumis Inc. | Grant or award | +3,553 | — | — |
| Jul 1, 2024 | Alumis Inc. | Sold back to the company | −23,529 | — | — |
| Jul 1, 2024 | Alumis Inc. | Grant or award | +23,529 | — | — |
Questions about Zhengbin Yao
What boards is Zhengbin Yao on?
Zhengbin Yao sits on the boards of Alumis Inc. and ArriVent BioPharma Inc.
What company is Zhengbin Yao the CEO of?
Zhengbin Yao has been President and CEO of ArriVent BioPharma Inc. since January 2024.
How long has Zhengbin Yao served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.